Skip to main content

Advertisement

Log in

Predictive factors and long-term prognosis of transcatheter aortic valve implantation-associated endocarditis

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

There are still limited data regarding transcatheter aortic valve implantation (TAVI) endocarditis.

Objectives

The objective of the present study was to investigate the predictor and long-term outcome of TAVI endocarditis.

Methods

Consecutive patients undergoing TAVI at the University of Bonn were prospectively enrolled in this study. Transcatheter heart valve (THV) endocarditis was defined according to Duke criteria. The primary outcome was all-cause death within a 5-year follow-up.

Results

1448 successful TAVI patients were eligible for the study and 17 patients (1.2%) developed THV endocarditis during the follow-up period (median 294 days). A multivariable logistic regression analysis identified age (odds ratio [OR] 0.90; P = 0.001) and residual paravalvular leakage (PVL) ≥ 2 after TAVI (OR 5.15; P = 0.015) as the main predictors for the occurrence of TAVI endocarditis. Additional analyses revealed that younger patients were significantly associated with higher rates of diabetes (P = 0.001), hemodialysis (P < 0.001), prior cardiac surgery (P < 0.001), and chronic obstructive pulmonary disease (COPD) (P < 0.001). A Kaplan–Meier analysis showed a significantly worse prognosis in TAVI patients with endocarditis than in patients without (log-rank; P = 0.03) during the 5-year follow-up. A multivariable Cox proportional hazard analysis revealed that TAVI endocarditis is an independent predictor of long-term mortality (hazard ratio 4.17; 95% CI 1.91–9.07; P < 0.001).

Conclusions

Our study identified lower age and residual PVL ≥ 2 as predictors for THV endocarditis, which itself may be considered as an independent predictor of long-term mortality after TAVI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Rodes-Cabau J (2011) Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 9:15–29

    Article  Google Scholar 

  2. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK, Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams M, Akin J, Davidson MJ, Svensson LG (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385:2477–2484

    Article  Google Scholar 

  3. Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrom T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Sondergaard L (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 65:2184–2194

    Article  Google Scholar 

  4. Waksman R, Rogers T, Torguson R, Gordon P, Ehsan A, Wilson SR, Goncalves J, Levitt R, Hahn C, Parikh P, Bilfinger T, Butzel D, Buchanan S, Hanna N, Garrett R, Asch F, Weissman G, Ben-Dor I, Shults C, Bastian R, Craig PE, Garcia-Garcia HM, Kolm P, Zou Q, Satler LF, Corso PJ (2018) Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis. J Am Coll Cardiol 72:2095–2105

    Article  Google Scholar 

  5. Nguyen V, Michel M, Eltchaninoff H, Gilard M, Dindorf C, Iung B, Mossialos E, Cribier A, Vahanian A, Chevreul K, Messika-Zeitoun D (2018) Implementation of transcatheter aortic valve replacement in France. J Am Coll Cardiol 71:1614–1627

    Article  Google Scholar 

  6. Kataruka A, Otto CM (2018) Valve durability after transcatheter aortic valve implantation. J Thorac Dis 10:S3629–s3636

    Article  Google Scholar 

  7. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL (2015) ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36:3075–3128

    Article  Google Scholar 

  8. Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U (2017) Prosthetic valve endocarditis after surgical aortic valve replacement. Circulation 136:329–331

    Article  Google Scholar 

  9. Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, Kapadia S, Lerakis S, Cheema AN, Gutierrez-Ibanes E, Munoz-Garcia AJ, Pan M, Webb JG, Herrmann HC, Kodali S, Nombela-Franco L, Tamburino C, Jilaihawi H, Masson JB, de Brito FS Jr, Ferreira MC, Lima VC, Mangione JA, Iung B, Vahanian A, Durand E, Tuzcu EM, Hayek SS, Angulo-Llanos R, Gomez-Doblas JJ, Castillo JC, Dvir D, Leon MB, Garcia E, Cobiella J, Vilacosta I, Barbanti M, Ribeiro HB, Urena M, Dumont E, Pibarot P, Lopez J, San Roman A, Rodes-Cabau J (2015) Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry. Circulation 131:1566–1574

    Article  Google Scholar 

  10. Olsen NT, De Backer O, Thyregod HG, Vejlstrup N, Bundgaard H, Sondergaard L, Ihlemann N (2015) Prosthetic valve endocarditis after transcatheter aortic valve implantation. Circ Cardiovasc Interv 8:e001939

    Article  CAS  Google Scholar 

  11. Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ (1985) Risk factors for the development of prosthetic valve endocarditis. Circulation 72:31–37

    Article  CAS  Google Scholar 

  12. Agnihotri AK, McGiffin DC, Galbraith AJ, O'Brien MF (1995) The prevalence of infective endocarditis after aortic valve replacement. J Thorac Cardiovasc Surg 110:1708–1720 (discussion 1720-1724)

    Article  CAS  Google Scholar 

  13. Regueiro A, Linke A, Latib A, Ihlemann N, Urena M, Walther T, Husser O, Herrmann HC, Nombela-Franco L, Cheema AN, Le Breton H, Stortecky S, Kapadia S, Bartorelli AL, Sinning JM, Amat-Santos I, Munoz-Garcia A, Lerakis S, Gutierrez-Ibanes E, Abdel-Wahab M, Tchetche D, Testa L, Eltchaninoff H, Livi U, Castillo JC, Jilaihawi H, Webb JG, Barbanti M, Kodali S, de Brito FS Jr, Ribeiro HB, Miceli A, Fiorina C, Dato GM, Rosato F, Serra V, Masson JB, Wijeysundera HC, Mangione JA, Ferreira MC, Lima VC, Carvalho LA, Abizaid A, Marino MA, Esteves V, Andrea JC, Giannini F, Messika-Zeitoun D, Himbert D, Kim WK, Pellegrini C, Auffret V, Nietlispach F, Pilgrim T, Durand E, Lisko J, Makkar RR, Lemos PA, Leon MB, Puri R, San Roman A, Vahanian A, Sondergaard L, Mangner N, Rodes-Cabau J (2016) Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death. JAMA 316:1083–1092

    Article  Google Scholar 

  14. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638

    Article  CAS  Google Scholar 

  15. Regev E, Finkelstein A, Assali A, Barbash I, Fefer P, Ben-Shoshan J, Orvin K, Konigstein M, Guetta V, Kornowski R, Segev A (2017) Comparison of outcome of transcatheter aortic valve implantation for severe aortic stenosis in 3 age groups (≤ 70; 71 to 80, and ≥ 81 years). Am J Cardiol 120:1607–1611

    Article  Google Scholar 

  16. Barth A, Yucel S, Ince H, Doblhammer G (2018) Impact of transcatheter aortic valve implantation on the risk of mortality in patients with severe aortic valve diseases: a health insurance-based analysis. Open Heart 5:e000756

    Article  Google Scholar 

  17. Karchmer AW, Dismukes WE, Buckley MJ, Austen WG (1978) Late prosthetic valve endocarditis: clinical features influencing therapy. Am J Med 64:199–206

    Article  CAS  Google Scholar 

  18. Gaudencio AM, Netto BM, Silva MR, Ferreira LM, Aguiar ET, Sato MK, Aun R, Langer B, Puech-Leao P (1998) Role of the process of endothelium formation on the wall of the aortic prosthesis in protection against infection. Experimental study in dogs. J Mal Vasc 23:102–105

    CAS  PubMed  Google Scholar 

  19. Angrist AA, Oka M (1963) Pathogenesis of bacterial endocarditis. JAMA 183:249–252

    Article  CAS  Google Scholar 

  20. Scheld WM, Valone JA, Sande MA (1978) Bacterial adherence in the pathogenesis of endocarditis Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest 61:1394–1404

    Article  CAS  Google Scholar 

  21. Rodbard S (1963) Blood velocity and endocarditis. Circulation 27:18–28

    Article  CAS  Google Scholar 

  22. Baddour LM, Bettmann MA, Bolger AF, Epstein AE, Ferrieri P, Gerber MA, Gewitz MH, Jacobs AK, Levison ME, Newburger JW, Pallasch TJ, Wilson WR, Baltimore RS, Falace DA, Shulman ST, Tani LY, Taubert KA (2003) Nonvalvular cardiovascular device-related infections. Circulation 108:2015–2031

    Article  Google Scholar 

  23. Sinning JM, Hammerstingl C, Vasa-Nicotera M, Adenauer V, Lema Cachiguango SJ, Scheer AC, Hausen S, Sedaghat A, Ghanem A, Muller C, Grube E, Nickenig G, Werner N (2012) Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol 59:1134–1141

    Article  Google Scholar 

  24. Athappan G, Patvardhan E, Tuzcu EM, Svensson LG, Lemos PA, Fraccaro C, Tarantini G, Sinning JM, Nickenig G, Capodanno D, Tamburino C, Latib A, Colombo A, Kapadia SR (2013) Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 61:1585–1595

    Article  Google Scholar 

  25. Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V, Rihal CS, Zajarias A, Doshi D, Davidson M, Tuzcu EM, Stewart W, Weissman NJ, Svensson L, Greason K, Maniar H, Mack M, Anwaruddin S, Leon MB, Hahn RT (2015) Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards sapien valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J 36:449–456

    Article  Google Scholar 

  26. Sinning JM, Stundl A, Pingel S, Weber M, Sedaghat A, Hammerstingl C, Vasa-Nicotera M, Mellert F, Schiller W, Kovac J, Welz A, Grube E, Werner N, Nickenig G (2016) Pre-procedural hemodynamic status improves the discriminatory value of the aortic regurgitation index in patients undergoing transcatheter aortic valve replacement. JACC Cardiovas Interv 9:700–711

    Article  Google Scholar 

  27. Sinning JM, Petronio AS, Van Mieghem N, Zucchelli G, Nickenig G, Bekeredjian R, Bosmans J, Bedogni F, Branny M, Stangl K, Kovac J, Nordell A, Schiltgen M, Piazza N, de Jaegere P (2017) Relation between clinical best practices and 6-month outcomes after transcatheter aortic valve implantation with CoreValve (from the ADVANCE II study). Am J Cardiol 119:84–90

    Article  Google Scholar 

Download references

Acknowledgements

We thank Ms. Meghan Campbell, a scientific coordinator in the Heart Center Bonn, for proofreading the manuscript.

Funding

Dr. Tabata was supported financially in part by a Fellowship from the Astellas Foundation for Research on Metabolic Disorders and the Uehara Memorial Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jan-Malte Sinning.

Ethics declarations

Conflict of interest

Drs. Sinning, Werner, and Nickenig have received speaker honoraria and research grants from Abbott, Abiomed, Medtronic, Boston Scientific, and Edwards Lifesciences. Dr. Tsujita has received grants from Abbott Vascular Japan, Medtronic Japan, and Boston Scientific Japan. The other authors report no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tabata, N., Al-Kassou, B., Sugiura, A. et al. Predictive factors and long-term prognosis of transcatheter aortic valve implantation-associated endocarditis. Clin Res Cardiol 109, 1165–1176 (2020). https://doi.org/10.1007/s00392-020-01609-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-020-01609-w

Keywords

Navigation